Barnaculate Carcinoma in Four Patients: Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants

Head and Neck Pathology 2026 Open access

Read full text
Authors: Yu Liang, Michelle Afkhami, Lester D.�R. Thompson, Hanlin Gao, Ellie G. Maghami, Massimo D’Apuzzo, Sue Chang, Diana Bell, Mihan Telatar, Thomas J. Gernon, Huiqing Wu
DOI: 10.1007/s12105-025-01870-3
Cited by: 0
References: 21

Abstract

Well-differentiated squamous cell carcinoma (SCC) in the oral cavity often has limited pleomorphism. Commonly seen in patients with proliferative verrucous leukoplakia, barnaculate carcinoma (BC) is a newly recognized, distinct subtype of well-differentiated SCC which presents with obvious architecture abnormalities but lacks significant pleomorphism. As such, reaching this diagnosis can be extremely challenging. In this study, molecular analysis of six BC specimens from four different patients demonstrated recurrent alterations in telomerase reverse transcriptase (TERT) promoter region and Harvey rat sarcoma virus (HRAS) gene. The identification of these oncogenic variants may be a useful adjunct to reaching the diagnosis.

Fields of Study & Subjects

Oral Health Pathology and Treatment Hedgehog Signaling Pathway Studies Nonmelanoma Skin Cancer Studies

Publication details

Journal / source
Head and Neck Pathology
Volume
20
Issue
1
Pages
6–6
Publication date
5 January 2026
Language
EN